U.S. pharmaceutical giant Eli Lilly (LLY) says it is preparing for the approval and launch of its new weight loss pill following the results of a late-stage clinical trial. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. The Indianapolis, Indiana-based …
Read More »Eli Lilly (LLY) Prepares for Weight Loss Pill Approval After Late-Stage Clinical Trial
